Therapeutic Role of Innovative Anti-Inflammatory Medications in the Prevention of Acute Coronary Syndrome

Cardiology in Review
Raymond Anthony Pashun, William H Frishman

Abstract

An improved understanding of the pathogenesis of acute coronary syndromes and its relationship to atherosclerotic plaque rupture and thrombosis has contributed to the investigation of novel therapies for prevention and treatment. New data ascribe an increasingly important role of active inflammation in contributing to thinning of the atherosclerotic fibrous cap and plaque instability. Despite this understanding, there are currently no therapeutic approaches to specifically target the unstable plaque. Multiple randomized trials investigating treatment strategies have recently been completed or are currently being conducted, using anti-inflammatory medications, such as methotrexate, colchicine, darapladib, varespladib, losmapimod, and canakinumab, to reduce the incidence of cardiovascular events including acute coronary syndromes. These anti-inflammatory medications differ in their mechanism of action from having widespread targets (as is the case for methotrexate and colchicine) to having specific targets (as is the case for darapladib, varespladib, losmapimod, and canakinumab). The trials investigating the efficacy of darapladib in reducing cardiovascular events revealed no significant benefit when compared with the current sta...Continue Reading

References

Sep 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·E P AmentoP Libby
Jul 1, 1988·Journal of the American College of Cardiology·J A AmbroseV Fuster
Mar 1, 1986·Journal of the American College of Cardiology·J A AmbroseV Fuster
Oct 1, 1965·Arthritis and Rheumatism·J E Caner
Jun 1, 1995·Circulation·P Libby
Feb 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J R KaplanT B Clarkson
Aug 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·J GaleaC M Holt
Dec 1, 1995·Atherosclerosis·M MenschikowskiW Jaross
Jul 17, 1998·The Journal of Clinical Investigation·L GenestierJ P Revillard
Dec 19, 1998·Journal of the American College of Cardiology·C BustosJ Egido
Nov 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·R DewberryS Francis
Dec 4, 2002·Circulation·Takahiko NarukoAnton E Becker
Feb 6, 2003·British Journal of Pharmacology·Darren C PhillipsHelen R Griffiths
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laurence QuéméneurLaurent Genestier
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Andrew Zalewski, Colin Macphee
May 26, 2005·Pharmacological Reviews·Bruce N Cronstein
Jun 6, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Zhihe LiAndrew A Protter
Sep 9, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Frank D KolodgieRenu Virmani
Nov 16, 2006·The New England Journal of Medicine·Judith S HochmanUNKNOWN Occluded Artery Trial Investigators
Mar 28, 2007·The New England Journal of Medicine·William E BodenUNKNOWN COURAGE Trial Research Group
Dec 18, 2007·Bioorganic & Medicinal Chemistry·Ashutosh TripathiSusan L Mooberry
Jul 22, 2008·Current Rheumatology Reports·George Nuki
Sep 4, 2008·Circulation·Patrick W SerruysUNKNOWN Integrated Biomarker and Imaging Study-2 Investigators
Oct 25, 2008·Cardiovascular Drugs and Therapy·Wolfgang Koenig, Natalie Khuseyinova

❮ Previous
Next ❯

Citations

Dec 14, 2019·Molecular Immunology·Vinicius Nunes Cordeiro LealAlessandra Pontillo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Clinical Therapeutics
Peter L ThompsonJohn W Eikelboom
Expert Review of Cardiovascular Therapy
Carlos M CamposHéctor M García-García
Current Treatment Options in Cardiovascular Medicine
Koto Ishida, Brett Cucchiara
European Heart Journal
Paul M Ridker, Thomas F Lüscher
© 2022 Meta ULC. All rights reserved